Kabi’s Sen Succeeds Sturm As Fresenius Chief
Head Of Fresenius Kabi Will Remain Leader Of Division Until A Successor Is Found
Fresenius Kabi CEO Michael Sen is set to replace Fresenius group chief executive Stephan Sturm from the start of October. He will remain head of Kabi until a successor is appointed.
You may also be interested in...
Unveiling plans to install a new bioreactor at its Genhelix site in Spain, mAbxience is bolstering its biosimilars manufacturing capabilities and CDMO capacity under the majority ownership of Fresenius Kabi.
Executive changes in 2022 reveal how the industry is adjusting to a volatile post-COVID environment.
Newly instated Fresenius group CEO Michael Sen took charge of his first earnings call following his appointment on 1 October, pushing the message of Kabi managing its own destiny amid a series of macroeconomic challenges.